Incomplete casemix and CMI data can weaken evidence-based advocacy, tariff evaluation, HTA, and equitable health financing. This infographic summarises key JKN 2024 pressures, data limitations, policy impacts, and strategic solutions.
Yan Aslian Noor
Medical Doctor I Senior Healthcare Executive I Writer